The Comparison of Insulin Resistance Between Normal and Early Menopause Women Younger than Fifty Years Old by Machine Learning Methods

利用机器学习方法比较50岁以下正常绝经女性和早期绝经女性的胰岛素抵抗

阅读:2

Abstract

Background: The prevalence of type 2 diabetes (T2D) is on the rise, and insulin resistance (IR) is one of the key risk factors for developing T2D. This paper seeks to identify risk factors for IR in women with normal menstrual cycles (NM) and early menopausal women (EM). Methods: EM women between 30 and 50 years old were compared with an NM control group. Four machine learning (ML) methods were trained using comprehensive physiological and lifestyle data to estimate a homeostasis model for insulin resistance (HOMA-IR dependent variable). Traditional multiple linear regression (MLR) was used as a benchmark for comparison. Results: A total of 948 participants were enrolled (NM: 410, EM: 538). On average, ML outperformed MLR, identifying the six key risk factors in the EM group (from most to least important) as waist-hip ratio (WHR), triglyceride (TG), glutamic-pyruvic transaminase (GPT), glutamic oxaloacetic transaminase (GOT), HDL-Cholesterol (HDL-C), and lactic dehydrogenase (LDH). Rankings differed in the NM group, with WHR identified as the leading risk factor, followed by C-reactive protein (CRP), HDL-C, total bilirubin (TBIL), diastolic blood pressure (DBP), and white blood cell count (WBC). Conclusions: Using ML, we found that WHR and HDL-C are the common denominators in both EM and NM women, with additional correlations with TG, liver enzymes and LDH for EM women. These results clearly indicate the importance of estrogen protection, suppressing less important factors (TG, liver enzyme, and LDH), and only the stronger inflammatory markers become important (CRP, TBIL, and WBC). Once estrogen's protection disappears, the suppression of CRP, TBIL, and WBC would become weaker. Since these 3 features are significantly correlated with body weight, for women under 50, reducing body weight is the most important factor in preventing hyperglycemia.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。